Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pazopanib with IMRT and Paclitaxel in Anaplastic Thyroid Cancer
NCT01236547Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Oct 2010
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pazopanib in anaplastic thyroid cancer (ATC), sponsored by National Cancer Institute. Started Oct 2010; status: completed.
02
Drugs
pazopanib
03
Conditions
anaplastic thyroid cancer (ATC)
Beyond the preview
Go deeper on NCT01236547.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01236547.